Cargando…

Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria

BACKGROUND: As of April 23, 2021, more than 145 million cases and almost 3.07 million related deaths were noted because of the coronavirus (Covid-19) Pandemic. Considering the low rate vaccination, the alternative that divided opinions for a long time is an old medicine called hydroxychloroquine. MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Aouissi, Hani Amir, Ababsa, Mostefa, Gaagai, Aissam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135374/
https://www.ncbi.nlm.nih.gov/pubmed/34035647
http://dx.doi.org/10.1186/s42269-021-00550-w
_version_ 1783695338976051200
author Aouissi, Hani Amir
Ababsa, Mostefa
Gaagai, Aissam
author_facet Aouissi, Hani Amir
Ababsa, Mostefa
Gaagai, Aissam
author_sort Aouissi, Hani Amir
collection PubMed
description BACKGROUND: As of April 23, 2021, more than 145 million cases and almost 3.07 million related deaths were noted because of the coronavirus (Covid-19) Pandemic. Considering the low rate vaccination, the alternative that divided opinions for a long time is an old medicine called hydroxychloroquine. MAIN BODY: The aim of this review was to synthesize the different highlights of the most important studies published since the beginning of the epidemic crisis. After a precise study of the available bibliography dealing with this subject and the addition of an adapted example, which is the current situation of Algeria, the results showed the effectiveness of the Algerian method as well as the impact that this treatment had. CONCLUSION: We concluded that in brief, given the inexistence of a better solution, we ultimately recommend that patients with severe COVID-19 to be treated for the moment with Hydroxychloroquine combined with Azithromycin in view of its effectiveness, while waiting for another solution.
format Online
Article
Text
id pubmed-8135374
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81353742021-05-21 Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria Aouissi, Hani Amir Ababsa, Mostefa Gaagai, Aissam Bull Natl Res Cent Review BACKGROUND: As of April 23, 2021, more than 145 million cases and almost 3.07 million related deaths were noted because of the coronavirus (Covid-19) Pandemic. Considering the low rate vaccination, the alternative that divided opinions for a long time is an old medicine called hydroxychloroquine. MAIN BODY: The aim of this review was to synthesize the different highlights of the most important studies published since the beginning of the epidemic crisis. After a precise study of the available bibliography dealing with this subject and the addition of an adapted example, which is the current situation of Algeria, the results showed the effectiveness of the Algerian method as well as the impact that this treatment had. CONCLUSION: We concluded that in brief, given the inexistence of a better solution, we ultimately recommend that patients with severe COVID-19 to be treated for the moment with Hydroxychloroquine combined with Azithromycin in view of its effectiveness, while waiting for another solution. Springer Berlin Heidelberg 2021-05-20 2021 /pmc/articles/PMC8135374/ /pubmed/34035647 http://dx.doi.org/10.1186/s42269-021-00550-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Aouissi, Hani Amir
Ababsa, Mostefa
Gaagai, Aissam
Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria
title Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria
title_full Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria
title_fullStr Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria
title_full_unstemmed Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria
title_short Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria
title_sort review of a controversial treatment method in the fight against covid-19 with the example of algeria
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135374/
https://www.ncbi.nlm.nih.gov/pubmed/34035647
http://dx.doi.org/10.1186/s42269-021-00550-w
work_keys_str_mv AT aouissihaniamir reviewofacontroversialtreatmentmethodinthefightagainstcovid19withtheexampleofalgeria
AT ababsamostefa reviewofacontroversialtreatmentmethodinthefightagainstcovid19withtheexampleofalgeria
AT gaagaiaissam reviewofacontroversialtreatmentmethodinthefightagainstcovid19withtheexampleofalgeria